VKORC1 gene variation and venous thrombosis: 'Another one bites the dust'?

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 10, 2007, Pages 2017-2019

  Reitsma, Pieter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; OSTEOCALCIN; OXIDOREDUCTASE; PHENPROCOUMON; PROTEIN C; PROTEIN S; PROTHROMBIN; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1; WARFARIN;

ALGORITHM; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; CARBOXYLATION; CEREBROVASCULAR ACCIDENT; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG RESPONSE; DRUG TARGETING; ENZYME ACTIVITY; GENE CONTROL; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; MIXED FUNCTION OXYGENASES; MODELS, BIOLOGICAL; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS); VENOUS THROMBOSIS;

EID: 34548832254     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02721.x     Document Type: Note

References (13)

1. Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, Muller CR, Strom TM, Oldenburg J. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537-41.
2. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature 2004; 427: 541-4.
3. D'Andrea G, D'Ambrosio RL, Di Perna P, Chetta M, Santacroce R, Brancaccio V, Grandone E, Margaglione M. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 2005; 105: 645-9.
4. Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005; 352: 2285-93.
5. Reitsma PH, van der Heijden JF, Groot AP, Rosendaal FR, Büller HR. A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk. PLoS Med 2005; 2: E312
6. Zhu Y., Shennan M, Reynolds KK, Johnson NA, Herrnberger MR, Valdes R Jr, Linder MW. Estimation of warfarin maintenance dose based on VKORC1 (-1639G> A) and CYP2C9 genotypes. Clin Chem 2007; 53: 1199-205.
7. Hamberg AK, Dahl ML, Barban M, Scordo MG, Wadelius M, Pengo V, Padrini R, Jonsson EN. A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy. Clin Pharmacol Ther 2007; 81: 529-38.
8. Wang Y, Zhang W, Zhang Y, Yang Y, Sun L, Hu S, Chen J, Zhang C, Zheng Y, Zhen Y, Sun K, Fu C, Yang T, Wang J, Sun J, Wu H, Glasgow WC, Hui R. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 2006; 113: 1615-21
9. Hindorff LA., Heckbert SR, Smith N, Marciante KD, Psaty BM. Common VKORC1 variants are not associated with arterial or venous thrombosis. J Thromb Haemost 2007; 5: 2025-7.
10. Lacut K, Larramendy-Gozalo C, Le Gal G, Duchemin J, Mercier B, Gourhant L, Mottier D, Becquemont L, Oger E, Verstuyft C. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: Results from the EDITH study. J Thromb Haemost 2007; 5: 2020-4.
11. Geisen C, Watzka M, Sittinger K, Steffens M, Daugela L, Seifried E, Muller CR, Wienker TF, Oldenburg J. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 2005; 94: 773-9.
12. Kimura R, Kokubo Y, Miyashita K, Otsubo R, Nagatsuka K, Otsuki T, Sakata T, Nagura J, Okayama A, Minematsu K, Naritomi H, Honda S, Sato K, Tomoike H, Miyata T. Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol 2006; 84: 387-97.
13. Watzka M, Nebel A, El Mokhtari NE, Ivandic B, Muller J, Schreiber S, Oldenburg J. Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans. Thromb Haemost 2007; 97: 998-1002.